1. What is the AI Index, anyway?

The AI Index is produced annually since 2017 by Stanford HAI (Human-Centered AI Institute)[1]. It pulls together research papers, patents, job postings, investment data, benchmark scores, policy moves, and public-opinion surveys — and stitches them into a single "report card" on AI. The 2026 edition runs over 400 pages. Researchers, journalists, businesses, and governments all start their AI conversations here. It is, in practice, the world's standard reference clock for AI.

The 2026 edition has a clear theme: "The year AI walked out of the lab and into everyday infrastructure." The following five numbers show why.

2. Number ① — Generative AI is spreading faster than PC or internet

39%
Share of US adults who report using generative AI in daily life. That curve is steeper than PC or internet adoption at the same stage.

By "generative AI" we mean tools like ChatGPT, Gemini, Claude, and Perplexity — AIs that produce text or images. The 2026 AI Index reports that nearly 4 out of 10 US adults now use these tools daily[1].

To see how fast this is, compare with the previous big technologies:

The reason is "no install required". No new hardware, no special software — just type a URL on your phone. Historically, almost no other consumer technology has had such low onboarding cost.

3. Number ② — The US-China model gap is closing

0.3%
Performance gap between leading US and Chinese AI models on major benchmarks, late 2024 → early 2026 (dramatically narrowed).

Until recently, the top AI models all came from the US — OpenAI (GPT), Google (Gemini), Anthropic (Claude). Chinese models like DeepSeek, Qwen, and Kimi were seen as technically a few steps behind.

The 2026 Index data shows that picture has changed[1]. On benchmarks like MMLU, HumanEval, and MATH, the gap between leading US and Chinese models has narrowed to under one percentage point. This is not just "China caught up" — it's a deeper shift: the know-how for AI is no longer one country's monopoly.

Lead author Nestor Maslej commented in interviews that "the benchmark performance gap is essentially gone for practical use cases. Future differentiation lies not in the model itself, but in application and operations."

4. Number ③ — Enterprises generated $172 billion from generative AI

$172B
Estimated economic value created by enterprises from generative AI in 2025. About ¥26 trillion equivalent.

This is a number that shows generative AI making actual money inside companies. Coding assistance, customer support, internal knowledge search, marketing-asset generation, code generation — when you add up the labor costs saved and new revenue created, the total comes to $172B[1][3].

For comparison: in 2023 the same estimate was about $50B. That's roughly a 3.5× jump in two years. "AI investment is a bubble" is a perennial worry, but at least on the income statement of large enterprises, AI is starting to show up as a real revenue line.

5. Number ④ — Data center power use has reached country scale

2.5%
Share of global electricity consumed by AI-related data centers in 2026 (estimate). Roughly equal to Argentina's total national electricity use.

A single ChatGPT query uses tens of times more energy than a Google search — that comparison is now widely known. AI Index 2026 reports that data-center electricity consumption climbed from 1.4% of global power in 2024 to 2.5% in 2026[1][4].

Projections suggest this could double again within five years. That's why Microsoft, Amazon, and Google are now siting new data centers next to nuclear power plants. The AI conversation is shifting from "how smart can it be?" to "how much electricity can we physically deliver to it?" — a question that's now geopolitical, not just technical.

Pharma comparison: A single training run of a large drug-discovery AI can use roughly the same electricity as a mid-sized pharmaceutical plant uses in a year.
The very tool accelerating drug discovery is generating its own environmental-ethics question — and that's becoming a new topic in pharma ethics.

6. Number ⑤ — AI is moving onto the device — edge AI for real

100%
With approaches like Perplexity's "Hybrid Agentic Inference", sensitive searches can now run "100% on-device", never leaving the user's machine.

Until recently, AI meant "cloud AI" — every query was sent to Microsoft, Google, or OpenAI servers for processing. Convenient, but hard to use for confidential information. Pharma clinical-trial data or patient information cannot be casually sent to external servers — that can be a regulatory violation.

That is changing. The AI Index highlights edge AI — running AI inside the device (PC, phone, local server) — as a major infrastructure trend of 2026[1][5].

A leading example is Perplexity's "Hybrid Agentic Inference", introduced in early 2026:

With this approach, queries like "Are there cases like this in our own clinical trial data?" can run without that data leaving the company. For pharma, healthcare, legal — the industries that cannot push data to the cloud — this is a decisive turning point.

7. What does it all mean?

Lined up, the five numbers tell a single story: "the AI conversation has shifted from technology to infrastructure."

AI is moving from "a toy" to "something on par with electricity and water". Just as no hospital operates without electricity, no workplace will operate without AI. The question is no longer "will you use it?" but "how will you use it, and where won't you?"

8. What to think about in pharma

This shift poses three questions to the pharmaceutical industry:

  1. Balancing confidentiality and utility ── With edge AI, you can now use AI assistance without pushing patient data outside the company. Areas previously written off as "cloud-impossible" (internal FAQ bots, knowledge search, adverse-event triage) are worth re-evaluating.
  2. Energy ethics ── What place does drug-discovery AI's electricity consumption have in a pharma company's ESG report? A company that publishes "environmental commitments" while running massive AI behind the scenes ── can that contradiction be explained honestly?
  3. The shifting axis of competition ── Differentiation by model performance is over. Competition is shifting to "how do you use your own patient and HCP data?" Data curation, privacy protection, regulatory know-how are the new competitive moats.

The AI Index isn't a pharma strategy document. But planning the next five years without reading the numbers in it is no longer possible.

Bibliography

  1. Stanford HAI, "Artificial Intelligence Index Report 2026", aiindex.stanford.edu/report/
  2. Maslej, N. et al., "AI Index Report 2026: Highlights", Stanford HAI Research Brief, 2026
  3. McKinsey & Company, "The economic potential of generative AI: Year-three update", 2026
  4. IEA (International Energy Agency), "Electricity 2026 — Data Centres and AI", iea.org/reports/
  5. Perplexity AI, "Introducing Hybrid Agentic Inference: Privacy-preserving local search", perplexity.ai/blog/
  6. Reuters, "China's AI models close gap with U.S. leaders, Stanford report finds", 2026